Search results
Results from the WOW.Com Content Network
The American Cancer Society recommends that men have a chance to make an informed decision with their health care provider about whether to be screened for prostate cancer. The decision should be made after getting information about the possible benefits, risks, and uncertainties of prostate cancer screening.
PSA-based screening for prostate cancer has both potential benefits and harms. The USPSTF does not recommend screening for prostate cancer unless men express a preference for screening after being informed of and understanding the benefits and risks.
Talk to your doctor, learn what is involved, and decide if a PSA test is right for you. Cancer screening means looking for cancer before it causes symptoms. The goal of screening for prostate cancer is to find cancers that may be at high risk for spreading if not treated, and to find them early before they spread.
Men who are 70 and older should not be screened for prostate cancer routinely. This recommendation applies to men who: Are at average risk for prostate cancer. Are at increased risk for prostate cancer. Do not have symptoms of prostate cancer. Have never been diagnosed with prostate cancer.
LAST UPDATED: Dec 21, 2023. The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation.
Review a consumer-friendly version of the American Cancer Society's screening guidelines for prostate cancer, as well as information on risk factors and methods of reducing risk.
Benefits of Early Detection and Treatment. The goal of screening for prostate cancer is to identify high-risk, localized prostate cancer that can be successfully treated, thereby preventing the morbidity and mortality associated with advanced or metastatic prostate cancer.
Prostate cancer screening may help detect prostate cancer, but remains controversial as it has not been shown to reduce deaths from prostate cancer. Learn more about prostate cancer screening, including the potential benefits and harms, in this expert-reviewed summary.
PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis...
Strategies and Evidence. Interpretation of PSA Levels. In the United States, a PSA level of 4.0 ng per milliliter has been the generally accepted thresh-old at which providers recommend...